Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodiol for gallstone prevention after bariatric surgery
NCT02319629Unknown
- Sponsor
- Emek Medical Center
- Start
- Dec 2014
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial in cholelithiasis comparing Ursodiol with Placebo (2 arms). Primary endpoint: Incidence of gallstones formation at 6 months. Status: unknown.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on NCT02319629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02319629.